Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis?
Lindhorst
Scott
S
Neurology Clinical Trials Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
Cudkowicz
Merit
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010431:Pentoxifylline / Q000009:adverse effects* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use*
D014665:Vasodilator Agents; D010431:Pentoxifylline